Nasal capsular cartilage is required for rat transpalatal suture morphogenesis

Differentiation

Volumn 71, Issue 8, 2003, Pages 496-505

  Adab, Katayoun ^a   Sayne, Jennifer R ^a   Carlson, David S ^a   Opperman, Lynne A ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

Bone growth; Craniofacial anomalies; Craniosynostosis; Nasal capsular cartilage; Transpalatal suture morphogenesis

Indexed keywords

GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL TISSUE; ARTICLE; BONE GROWTH; DURA MATER; FETUS; GENE EXPRESSION; MORPHOGENESIS; NONHUMAN; NOSE CARTILAGE; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKULL; SUTURE; TISSUE INTERACTION;

ANIMALIA; MAMMALIA;

EID: 0242266102     PISSN: 03014681     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-0436.2003.7108003.x     Document Type: Article

References (37)

1. Adab, K., Sayne, J.R., Carlson, D.S. and Opperman, L.A. (2002) Tgf-β1, Tgf-β2, Tgf-β3 and Msx2 expression during rat frontonasal suture morphogenesis and postnatal facial growth. Orthod Craniofac Res 5:227-237.
2. Babler, W. (1989) Relationship of altered cranial suture growth to cranial base and midface. In: Persing, J.A., Edgerton, M.T. and Jane, J.A. (eds) Scientific foundations and surgical treatment of craniosynostosis. Williams and Wilkins, Baltimore, pp 87-95.
3. Bellus, G.A., Gaudenz, K., Zackai, E.H., Clarke, L.A., Szabo, J., Francomano, C.A. and Muenke, M. (1996) Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet 14:174-176.
4. Chong, S.L., Mitchell, R., Moursi, A.M., Winnard, P., Losken, H.W., Bradley, J., Ozerdem, O., Azari, K., Acarturk, O. and Opperman, L.A., et al (2003) Rescue of coronal suture fusion using transforming growth factor-β3 (Tgf-β3) in rabbits with delayed-onset craniosynostosis. Anat Rec 274:962-971.
5. Cohen, M.M.J. (2000) Craniosynostosis: diagnosis, evaluation, and management. Oxford University Press, New York.
6. Enlow, D.H. (2000) Normal craniofacial growth. In: Cohen, M.M.J. and MacLean, R.E. (eds) Craniosynostosis: diagnosis, evaluation, and management. Oxford University Press, New York, pp 35-50.
7. Gygi, S.P., Rochon, Y., Franza, B.R. and Aebersold, R. (1999) Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19:1720-1730.
8. Ignelzi, M.A. Jr., Wang, W. and Young, A.T. (2003) Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures. J Bone Miner Res 18:751-759.
9. Jabs, E.W., Muller, U., Li, X., Ma, L., Luo, W., Haworth, I.S., Klisak, I., Sparkes, R., Warman, M.L. and Mulliken, J.B., et al. (1993) A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75:443-450.
10. Jabs, E.W., Li, X., Scott, A.F., Meyers, G., Chen, W., Eccles, M., Mao, J.I., Charnas, L.R., Jackson, C.E. and Jaye, M. (1994) Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet 8:275-279; erratum, 1995, Nat Genet 9:451.
11. Kim, H.J., Rice, D.P., Kettunen, P.J. and Thesleff, I. (1998) FGF-, BMP-and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 125:1241-1251.
12. Kokich, V.G. (1986) The biology of sutures. In: Cohen, M.M.J. (ed) Craniosynostosis: diagnosis, evaluation and management. Raven Press, New York, pp 81-103.
13. Kreiborg, S. (2000) Postnatal growth and development of the craniofacial complex in premature craniosynostosis. In: Cohen, M.M.J. (ed) Craniosynostosis: diagnosis, evaluation and management. Oxford University Press. New York, pp 158-174.
14. Massague, J., Blain, S.W. and Lo, R.S. (2000) Tgfβ signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
15. Massler, M. and Schour, I. (1951) The growth pattern of the cranial vault in the albino rat as measured by vital staining with alizarin red "S". Anat Rec 110:83-101.
16. Moss, M.L. (1954) Growth of the calvaria in the rat. The determination of osseous morphology. Am J Anat 94:333-362.
17. Moss, M.L. (1962) The functional matrix. In: Kraus, B.S. and Riedel, R.A. (eds) Vistas in orthodontics. Lea and Febiger, Philadelphia, pp 85-98.
18. Moursi, A.M., Winnard, P.L., Winnard, A.V., Rubenstrunk, J.M. and Mooney, M.P. (2002) Fibroblast growth factor 2 induces increased calvarial osteoblast proliferation and cranial suture fusion. Cleft Palate Craniofac J 39:487-496.
19. Muenke, M. and Beachy, P.A. (2000) Genetics of ventral forebrain development and holoprosencephaly. Curr Opin Genet Dev 10:262-269.
20. Muenke, M., Schell, U., Hehr, A., Robin, N.H., Losken, H.W., Schinzel, A., Pulleyn, L.J., Rutland, P., Reardon, W. and Malcolm, S., et al. (1994) A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 8:269-274.
21. Myers, G.A., Orlow, S.J., Munro, J.R., Przylepa, K.A. and Jabs, E.W. (1995) Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 11:462-464.
22. Opperman, L.A., Passarelli, R.W., Morgan, E.P., Reintjes, M. and Ogle, R.C. (1995) Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Miner Res 10:1978-1987.
23. Opperman, L.A., Passarelli, R.W., Nolen, A.A., Gampper, T.J., Lin, K.Y. and Ogle, R.C. (1996) Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In Vitro Cell Dev Biol Anim 32:627-632.
24. Opperman, L.A., Nolen, A.A. and Ogle, R.C. (1997) TGF-β1, TGF-β2, and TGF-β3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Miner Res 12:301-310.
25. Opperman, L.A., Chhabra, A., Nolen, A.A., Bao, Y. and Ogle, R.C. (1998) Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production. J Craniofac Genet Dev Biol 18:150-158.
26. Opperman, L.A., Chhabra, A., Cho, R.W. and Ogle, R.C. (1999) Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-β3 activity and prevented by removal of TGF-β2 activity from fetal rat calvaria in vitro. J Craniofac Genet Dev Biol 19:164-173.
27. Opperman, L.A., Adab, K. and Gakunga, P.T. (2000) TGF-β2 and TGF-β3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev Dyn 219:237-247.
28. Opperman, L.A., Moursi, A., Sayne, J.R. and Wintergerst, A.M. (2002) Transforming growth factor-β3 (Tgf-β3) in a collagen gel delays fusion of the rat posterior interfrontal suture in vivo. Anat Rec 267:120-130.
29. Reardon, W., Winter, R.M., Rutland, P., Pulleyn, L.J., Jones, B.M. and Malcolm, S. (1994) Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 8: 98-103.
30. Roth, D.A., Bradley, J.P., Levine, J.P., McMullen, H.F., McCarthy, J.G. and Longaker, M.T. (1996) Studies in cranial suture biology: part II. Role of the dura in cranial suture fusion. Plast Reconstr Surg 97:693-699.
31. Roth, D.A., Gold, L.I., Han, V.K., McCarthy, J.G., Sung, J.J., Wisoff, J.H. and Longaker, M.T. (1997) Immunolocalization of transforming growth factor β1, β2, and β3 and insulin-like growth factor I in premature cranial suture fusion. Plast Reconstr Surg 99:300-309; discussion 310-316.
32. Sarnat, B.G. (1963) Postnatal growth of the upper face. Angle Orthod 33:139.
33. Scott, J.H. (1953a) The cartilage of the nasal septum. British Dent J 95:37-40.
34. Scott, J.H. (1953b) Growth of the human face. Proc Royal Soc Med 47:91-100.
35. Scott, J.H. (1956) Growth at the facial sutures. Am J Orthod 42:381-387.
36. Warren, S.M., Brunet, L.J., Harland, R.M., Economides, A.N. and Longaker, M.T. (2003) The BMP antagonist noggin regulates cranial suture fusion. Nature 422:625-629.
37. Wilkie, A.O., Slaney, S.F., Oldridge, M., Poole, M.D., Ashworth, G.J., Hockley, A.D., Hayward, R.D., David, D.J., Pulleyn, L.J. and Rutland, P., et al. (1995) Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9:165-172.